These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 10875787

  • 1. Mucosal bacille calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses.
    Hoft DF, Brown RM, Belshe RB.
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S217-22. PubMed ID: 10875787
    [Abstract] [Full Text] [Related]

  • 2. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
    Kawahara M, Matsuo K, Honda M.
    Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
    [Abstract] [Full Text] [Related]

  • 3. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.
    Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, Ngwira B, Sichali L, Nazareth B, Blackwell JM, Branson K, Chaguluka SD, Donovan L, Jarman E, King E, Fine PE, Dockrell HM.
    Lancet; 2002 Apr 20; 359(9315):1393-401. PubMed ID: 11978337
    [Abstract] [Full Text] [Related]

  • 4. The cytokine response to bacille Calmette Guérin vaccination in South India.
    Das SD, Narayanan PR, Kolappan C, Colston MJ.
    Int J Tuberc Lung Dis; 1998 Oct 20; 2(10):836-43. PubMed ID: 9783532
    [Abstract] [Full Text] [Related]

  • 5. Monocyte response receptors in BCG driven delayed type hypersensitivity to tuberculin.
    Strapagiel D, Kasztalska K, Druszczyńska M, Kowalewicz-Kulbat M, Vrba A, Matusiak A, Chmiela M, Rudnicka W.
    Folia Histochem Cytobiol; 2008 Oct 20; 46(3):353-9. PubMed ID: 19056540
    [Abstract] [Full Text] [Related]

  • 6. Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi.
    Black GF, Fine PEM, Warndorff DK, Floyd S, Weir RE, Blackwell JM, Bliss L, Sichali L, Mwaungulu L, Chaguluka S, Jarman E, Ngwira B, Dockrell HM.
    Int J Tuberc Lung Dis; 2001 Jul 20; 5(7):664-72. PubMed ID: 11467373
    [Abstract] [Full Text] [Related]

  • 7. Kinetics of delayed-type hypersensitivity to tuberculin induced by bacille Calmette-Guérin vaccination in northern Malawi.
    Floyd S, Pönnighaus JM, Bliss L, Nkhosa P, Sichali L, Msiska G, Fine PE.
    J Infect Dis; 2002 Sep 15; 186(6):807-14. PubMed ID: 12198615
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccination.
    Hoft DF, Leonardi C, Milligan T, Nahass GT, Kemp B, Cook S, Tennant J, Carey M.
    Clin Infect Dis; 1999 Apr 15; 28(4):785-90. PubMed ID: 10825039
    [Abstract] [Full Text] [Related]

  • 10. Persistence and boosting of bacille Calmette-Guérin-induced delayed-type hypersensitivity.
    Hoft DF, Tennant JM.
    Ann Intern Med; 1999 Jul 06; 131(1):32-6. PubMed ID: 10391813
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of high-dose vitamin A supplementation on the immune response to Bacille Calmette-Guerin vaccine.
    Diness BR, Fisker AB, Roth A, Yazdanbakhsh M, Sartono E, Whittle H, Nante JE, Lisse IM, Ravn H, Rodrigues A, Aaby P, Benn CS.
    Am J Clin Nutr; 2007 Oct 06; 86(4):1152-9. PubMed ID: 17921396
    [Abstract] [Full Text] [Related]

  • 13. Booster effect of tuberculin testing in healthy 6-year-old school children vaccinated with Bacillus Calmette-Guérin at birth in Santiago, Chile.
    Sepulveda RL, Burr C, Ferrer X, Sorensen RU.
    Pediatr Infect Dis J; 1988 Aug 06; 7(8):578-81. PubMed ID: 3140208
    [Abstract] [Full Text] [Related]

  • 14. Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture.
    Katial RK, Hershey J, Purohit-Seth T, Belisle JT, Brennan PJ, Spencer JS, Engler RJ.
    Clin Diagn Lab Immunol; 2001 Mar 06; 8(2):339-45. PubMed ID: 11238218
    [Abstract] [Full Text] [Related]

  • 15. Clinical inquiries. How should we manage a patient with a positive PPD and prior BCG vaccination?
    Rowland K, Guthmann R, Jamieson B, Malloy D.
    J Fam Pract; 2006 Aug 06; 55(8):718-20. PubMed ID: 16882448
    [Abstract] [Full Text] [Related]

  • 16. PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis.
    Elias D, Akuffo H, Britton S.
    Trans R Soc Trop Med Hyg; 2005 May 06; 99(5):363-8. PubMed ID: 15780343
    [Abstract] [Full Text] [Related]

  • 17. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection.
    Thom M, Howard C, Villarreal-Ramos B, Mead E, Vordermeier M, Hope J.
    Tuberculosis (Edinb); 2008 Jul 06; 88(4):324-34. PubMed ID: 18329343
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, placebo-controlled study of Mycobacterium-specific human immune responses induced by intradermal bacille Calmette-Guérin vaccination.
    Hoft DF, Kemp EB, Marinaro M, Cruz O, Kiyono H, McGhee JR, Belisle JT, Milligan TW, Miller JP, Belshe RB.
    J Lab Clin Med; 1999 Sep 06; 134(3):244-52. PubMed ID: 10482309
    [Abstract] [Full Text] [Related]

  • 19. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M, D'Souza S, Adnet PY, Laali R, Jurion F, Palfliet K, Huygen K.
    Vaccine; 2006 Apr 12; 24(16):3353-64. PubMed ID: 16488518
    [Abstract] [Full Text] [Related]

  • 20. Vaccination of cattle with Mycobacterium bovis BCG by a combination of systemic and oral routes.
    Buddle BM, Denis M, Aldwell FE, Martin Vordermeier H, Glyn Hewinson R, Neil Wedlock D.
    Tuberculosis (Edinb); 2008 Nov 12; 88(6):595-600. PubMed ID: 18439875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.